FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SOON-SHIONG PATRICK
2. Issuer Name and Ticker or Trading Symbol

NantHealth, Inc. [ NH ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD.
3. Date of Earliest Transaction (MM/DD/YYYY)

4/13/2021
(Street)

CULVER CITY, CA 90232
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 4/13/2021  P  1689189 A$2.96 1689189 I See footnote (1)
Common Stock         62214114 I See footnote (2)
Common Stock         2899297 I See footnote (3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
5.50% Convertible Senior Notes due 2021  (4)4/13/2021  J (5)    5000000 (5)  (6)12/15/2021 Common Stock 411946 (4)$5000000.00 5000000 I See Footnote (7)

Explanation of Responses:
(1) Shares are held by Cambridge Equities, LP ("Cambridge Equities"), an entity affiliated with MP 13 Ventures, LLC ("MP 13 Ventures") who is the general partner of Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the shares held by Cambridge Equities.
(2) Shares held by NantWorks. California Capital Equity, LLC ("CalCap") directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap.
(3) Shares held by NantOmics, LLC ("NantOmics"). NantWorks directly owns a majority of the equity interests of NantOmics. CalCap directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap.
(4) The initial conversion rate of the 5.50% Convertible Senior Notes due 2021 (the "Notes") is 82.3893 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $12.14 per share), subject to adjustment pursuant to the terms of the Notes.
(5) Portion of the Convertible Senior Note was forgiven as consideration for the purchase of shares reported in Table I.
(6) The Notes will be convertible at the option of the reporting persons only upon the satisfaction of certain conditions prior to the close of business on the business day immediately preceding September 15, 2021. Thereafter, the Notes will be convertible at the option of the reporting persons at any time or after September 15, 2021 until the close of business on the business day immediately preceding the maturity date. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election.
(7) The Notes are held by Cambridge Equities, an entity affiliated with MP 13 Ventures, LLC who is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the convertible notes held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the convertible notes held by Cambridge Equities.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
SOON-SHIONG PATRICK
C/O NANTHEALTH, INC.
9920 JEFFERSON BLVD.
CULVER CITY, CA 90232
XXChief Executive Officer
CALIFORNIA CAPITAL EQUITY, LLC
C/O NANTHEALTH, INC.
9920 JEFFERSON BLVD.
CULVER CITY 90230

X

NantWorks, LLC
9920 JEFFERSON BLVD.
CULVER CITY, CA 90230

X

Cambridge Equities, LP
9920 JEFFERSON BLVD.
CULVER CITY, CA 90232

X

MP 13 Ventures, LLC
9920 JEFFERSON BLVD.
CULVER CITY, CA 90232

X


Signatures
/s/ Patrick Soon-Shiong on behalf of himself and each other reporting person4/15/2021
**Signature of Reporting PersonDate

NantHealth (NASDAQ:NH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more NantHealth Charts.
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more NantHealth Charts.